169 related articles for article (PubMed ID: 33081486)
21. CT and
Altinmakas E; Üçışık-Keser FE; Medeiros LJ; Ng CS
Acad Radiol; 2019 Jun; 26(6):e108-e114. PubMed ID: 30076085
[TBL] [Abstract][Full Text] [Related]
22. 99mTc-Methionine Hybrid SPECT/CT for Detection of Recurrent Glioma: Comparison With 18F-FDG PET/CT and Contrast-Enhanced MRI.
Arora G; Sharma P; Sharma A; Mishra AK; Hazari PP; Biswas A; Garg A; Aheer D; Kumar R
Clin Nucl Med; 2018 May; 43(5):e132-e138. PubMed ID: 29517540
[TBL] [Abstract][Full Text] [Related]
23.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
24. Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by
Heidemeier A; Schloetelburg W; Thurner A; Metz C; Heidemeier H; Rasche L; Martin Kortuem K; Boeckle D; Weiland E; Benkert T; Nickel D; Werner R; Buck AK; Bley TA
Eur J Radiol; 2022 Oct; 155():110493. PubMed ID: 36027759
[TBL] [Abstract][Full Text] [Related]
25. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Liu Y
Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
[TBL] [Abstract][Full Text] [Related]
26. Determination of brain tumor recurrence using
Yamaguchi S; Hirata K; Okamoto M; Shimosegawa E; Hatazawa J; Hirayama R; Kagawa N; Kishima H; Oriuchi N; Fujii M; Kobayashi K; Kobayashi H; Terasaka S; Nishijima KI; Kuge Y; Ito YM; Nishihara H; Tamaki N; Shiga T
Cancer Sci; 2021 Oct; 112(10):4246-4256. PubMed ID: 34061417
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of
He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
[TBL] [Abstract][Full Text] [Related]
28. Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system.
Okochi Y; Nihashi T; Fujii M; Kato K; Okada Y; Ando Y; Maesawa S; Takebayashi S; Wakabayashi T; Naganawa S
Ann Nucl Med; 2014 Feb; 28(2):94-102. PubMed ID: 24272066
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F
Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990
[TBL] [Abstract][Full Text] [Related]
30.
Tomura N; Saginoya T; Kaneko C
World J Nucl Med; 2022 Dec; 21(4):261-266. PubMed ID: 36398309
[No Abstract] [Full Text] [Related]
31. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract][Full Text] [Related]
33. Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.
Sato N; Inoue T; Tomiyoshi K; Aoki J; Oriuchi N; Takahashi A; Otani T; Kurihara H; Sasaki T; Endo K
Neuroradiology; 2003 Oct; 45(10):700-7. PubMed ID: 13680026
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
[TBL] [Abstract][Full Text] [Related]
35. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
Kawai N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
[TBL] [Abstract][Full Text] [Related]
36. Clinical application of combination [
Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
[TBL] [Abstract][Full Text] [Related]
37.
Wardak M; Sonni I; Fan AP; Minamimoto R; Jamali M; Hatami N; Zaharchuk G; Fischbein N; Nagpal S; Li G; Koglin N; Berndt M; Bullich S; Stephens AW; Dinkelborg LM; Abel T; Manning HC; Rosenberg J; Chin FT; Gambhir SS; Mittra ES
Radiology; 2022 Jun; 303(3):620-631. PubMed ID: 35191738
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary mucosa-associated lymphoid tissue lymphoma:
Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
[TBL] [Abstract][Full Text] [Related]
39. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]